Takeda's Nycomed buyout wins E.U. nod; Novo to relocate North American HQ;
@FiercePharma: Add another state AG to the list of Risperdal plaintiffs. Now it's Mass. claiming J&J's marketing crossed the line. News | Follow @FiercePharma
Takeda's $13.68 billion acquisition of the Swiss drugmaker Nycomed won regulatory approval in the E.U. News
Novo Nordisk plans to move its North American headquarters to Plainsboro, NJ, from Princeton, bringing 1,200 jobs along with it. Item
The FDA found counterfeit versions of the morning-after birth control pill Evital imported for sale in the U.S., where the drug is not approved. Article
Pfizer wrapped up the sale of its Capsugel unit to the investment firm KKR for $2.3 billion in cash. Pfizer release
GlaxoSmithKline's new epilepsy drug Trobalt got a thumbs up from the U.K.'s cost-effectiveness watchdog for use as an add-on therapy. Story
Ranbaxy Laboratories and parent company Daiichi Sankyo will expand their Mexican footprint with the launch of a generic version of the blood pressure drug Benicar. Item
Hungary's Geodon Richter saw second-quarter profit drop by 68% on higher sales and marketing costs associated with its development of a sales network in former Soviet bloc countries. Report
Biotech News
@FierceBiotech: Teva's oral MS drug trips (again) in blockbuster Ph3 development race. News | Follow @FierceBiotech
@JohnCFierce: Arena makes case that lorcaserin shouldn't significantly increase risk of brain tumors. But can they convince FDA? Article | Follow @JohnCFierce
@RyanMFierce: Sequencing giant BGI shoots for the cloud, look out Complete Genomics? Item | Follow @RyanMFierce
@MaureenFierce: Actelion's experimental multiple sclerosis drug ponesimod met main goal in Phase II trial. Piece | Follow @MaureenFierce
Insmed shares crater as FDA puts a clamp of Ph3 CF study. Story
Can Arena's latest safety study help satisfy FDA cancer worries? Report
Biotech Research News
U.S. gives out $5M for antiradiation drugs in case of attack. Item
Leukemia drug helps reverse tamoxifen resistance in breast cancer. News
A transcriptional time machine may turn back the clock on leukemia. Article
Genes help personalized stomach cancer treatments. Report
Of mice, men, sex, and violence. Story
Nicotine eyed as Parkinson's treatment. More
Manufacturing News
How an ops driving lesson may have saved former Pfizer CEO Kindler. More
Shippers organize air cargo to win over pharma. Story
UN: Pharma CMOs fare well in investment by developing countries. Article
Compounding pharmacies shine during drug shortages. Report
And Finally... GlaxoSmithKline has been using reverse auctions to drive down legal fees, spooking law firms. Report
Summary
@FiercePharma: Add another state AG to the list of Risperdal plaintiffs. Now it's Mass. claiming J&J's marketing crossed the line. News | Follow @FiercePharma > Takeda's $13.68 billion